{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:50:02Z","timestamp":1793832602849,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"INRC; National Institute for Cardiovascular Research"},{"name":"US National Processed Raspberry Council","award":["2014-9"],"award-info":[{"award-number":["2014-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0561-3","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T09:16:27Z","timestamp":1499332587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats"],"prefix":"10.1186","volume":"16","author":[{"given":"Monia","family":"Savi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Dall\u2019Asta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Brighenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Stilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-1259","authenticated-orcid":false,"given":"Daniele","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"561_CR1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57:660\u201371.","journal-title":"Diabetologia"},{"key":"561_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/nu8110729","volume":"8","author":"M Savi","year":"2016","unstructured":"Savi M, Bocchi L, Sala R, Frati C, Lagrasta C, Madeddu D, Falco A, Pollino S, Bresciani L, Miragoli M, Zaniboni M, Quaini F, Del Rio D, Stilli D. Parenchymal and stromal cells contribute to pro-inflammatory myocardial environment at early stages of diabetes: protective role of resveratrol. Nutrients. 2016;8:729\u201350.","journal-title":"Nutrients"},{"key":"561_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo B, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142:375\u2013415.","journal-title":"Pharmacol Ther"},{"key":"561_CR4","doi-asserted-by":"crossref","first-page":"652097","DOI":"10.1155\/2011\/652097","volume":"2011","author":"O Lorenzo","year":"2011","unstructured":"Lorenzo O, Picatoste B, Ares-Carrasco S, Ramirez E, Egido J, Tunon J. Potential role of nuclear factor KB in diabetic cardiomyopathy. Mediat Inflamm. 2011;2011:652097.","journal-title":"Mediat Inflamm"},{"key":"561_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/B978-0-12-405885-9.00021-8","volume-title":"Diabetes: oxidative stress and dietary antioxidants","author":"SJ Kim","year":"2014","unstructured":"Kim SJ. Herbal chrysanthemi flos, oxidative damage and protection against diabetic complications. In: Preedy Victor, editor. Diabetes: oxidative stress and dietary antioxidants. Amsterdam: Elsevier; 2014. p. 201\u201311."},{"key":"561_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/B978-0-12-405885-9.00017-6","volume-title":"Diabetes: oxidative stress and dietary antioxidants","author":"S Lim","year":"2014","unstructured":"Lim S, Park KS. The use of Ginkgo biloba extract in cardiovascular protection in patients with diabetes. In: Preedy Victor, editor. Diabetes: oxidative stress and dietary antioxidants. Amsterdam: Elsevier; 2014. p. 165\u201372."},{"key":"561_CR7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","volume":"56","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, B\u00e1tkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horv\u00e1th B, Mukhopadhyay B, Becker L, Hask\u00f3 G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56:2115\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"561_CR8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jff.2015.01.006","volume":"13","author":"L Li","year":"2015","unstructured":"Li L, Xu J, Mu Y, Han L, Liu R, Cai Y, Huang X. Chemical characterization and anti-hyperglycaemic effects of polyphenol enriched longan (Dimocarpus longan Lour.) pericarp extracts. J Funct Foods. 2015;13:314\u201322.","journal-title":"J Funct Foods"},{"key":"561_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C4FO00670D","volume":"6","author":"I Zanotti","year":"2015","unstructured":"Zanotti I, Dall\u2019Asta M, Mena P, Mele L, Bruni R, Ray S, Del Rio D. Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct. 2015;6:13\u201331.","journal-title":"Food Funct"},{"key":"561_CR10","doi-asserted-by":"crossref","first-page":"270418","DOI":"10.1155\/2013\/270418","volume":"2013","author":"JC Esp\u00edn","year":"2013","unstructured":"Esp\u00edn JC, Larrosa M, Garc\u00eda-Conesa MT, Tom\u00e1s-Barber\u00e1n F. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013;2013:270418.","journal-title":"Evid Based Complement Alternat Med"},{"key":"561_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3945\/an.115.009639","volume":"7","author":"BM Burton-Freeman","year":"2016","unstructured":"Burton-Freeman BM, Sandhu AK, Edirisinghe I. Red raspberries and their bioactive polyphenols: cardiometabolic and neuronal health links. Adv Nutr. 2016;7:44\u201365.","journal-title":"Adv Nutr"},{"key":"561_CR12","doi-asserted-by":"crossref","first-page":"1500901","DOI":"10.1002\/mnfr.201500901","volume":"61","author":"FA Tom\u00e1s-Barber\u00e1n","year":"2017","unstructured":"Tom\u00e1s-Barber\u00e1n FA, Gonz\u00e1lez-Sarr\u00edas A, Garc\u00eda-Villalba R, N\u00fa\u00f1ez-S\u00e1nchez MA, Selma MV, Garc\u00eda-Conesa MT, Esp\u00edn JC. Urolithins, the rescue of \u201cold\u201d metabolites to understand a \u201cnew\u201d concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res. 2017;61:1500901.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jff.2015.03.019","volume":"15","author":"R Sala","year":"2015","unstructured":"Sala R, Mena P, Savi M, Brighenti F, Crozier A, Miragoli M, Stilli D, Del Rio D. Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. J Funct Foods. 2015;15:97\u2013105.","journal-title":"J Funct Foods"},{"key":"561_CR14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.freeradbiomed.2015.10.400","volume":"89","author":"IA Ludwig","year":"2015","unstructured":"Ludwig IA, Mena P, Calani L, Borges G, Pereira-Caro G, Bresciani L, Del Rio D, Lean MEJ, Crozier A. New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic Biol Med. 2015;89:758\u201369.","journal-title":"Free Radic Biol Med"},{"key":"561_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.abb.2016.02.017","volume":"599","author":"L Mele","year":"2016","unstructured":"Mele L, Mena P, Piemontese A, Marino V, L\u00f3pez-Guti\u00e9rrez N, Bernini F, Brighenti F, Zanotti I, Del Rio D. Antiatherogenic effects of ellagic acid and urolithins in vitro. Arch Biochem Biophys. 2016;599:42\u201350.","journal-title":"Arch Biochem Biophys"},{"key":"561_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1113\/jphysiol.1994.sp020130","volume":"476","author":"JWM Bassani","year":"1994","unstructured":"Bassani JWM, Bassani RA, Bers DM. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol. 1994;476:279\u201393.","journal-title":"J Physiol"},{"key":"561_CR17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0008-6363(02)00694-6","volume":"57","author":"KF Frank","year":"2003","unstructured":"Frank KF, B\u00f6lck B, Erdmann E, Schwinger RH. Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res. 2003;57:20\u20137.","journal-title":"Cardiovasc Res"},{"key":"561_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ceca.2014.09.005","volume":"56","author":"A Zarain-Herzberg","year":"2014","unstructured":"Zarain-Herzberg A, Garc\u00eda-Rivas G, Estrada-Avil\u00e9s R. Regulation of SERCA pumps expression in diabetes. Cell Calcium. 2014;56:302\u201310.","journal-title":"Cell Calcium"},{"key":"561_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2840-13-75","volume":"13","author":"SM Zhao","year":"2014","unstructured":"Zhao SM, Wang YL, Guo CY, Chen JL, Wu YQ. Progressive decay of Ca2\u00a0+\u00a0homeostasis in the development of diabetic cardiomyopathy. Cardiovasc Diabetol. 2014;13:75.","journal-title":"Cardiovasc Diabetol."},{"key":"561_CR20","doi-asserted-by":"crossref","first-page":"e39893","DOI":"10.1371\/journal.pone.0039893","volume":"7","author":"A Takada","year":"2012","unstructured":"Takada A, Miki T, Kuno A, Kouzu H, Sunaga D, Itoh T, Tanno M, Yano T, Sato T, Ishikawa S, Miura T. Role of ER stress in ventricular contractile dysfunction in type 2 diabetes. PLoS ONE. 2012;7:e39893.","journal-title":"PLoS ONE"},{"key":"561_CR21","doi-asserted-by":"crossref","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","volume":"298","author":"M Sulaiman","year":"2010","unstructured":"Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2010;298:H833\u201343.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"561_CR22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/BF02977654","volume":"30","author":"L Kang","year":"2007","unstructured":"Kang L, Fang Q, Hu SJ. Regulation of phospholamban and sarcoplasmic reticulum Ca2+-ATPase by atorvastatin: implication for cardiac hypertrophy. Arch Pharm Res. 2007;30:596\u2013602.","journal-title":"Arch Pharm Res"},{"key":"561_CR23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI118446","volume":"97","author":"VJ Kadambi","year":"1996","unstructured":"Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest. 1996;97:533\u20139.","journal-title":"J Clin Invest"},{"key":"561_CR24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1113\/EP085104","volume":"100","author":"X Gu","year":"2015","unstructured":"Gu X, Xu J, Yang XP, Peterson E, Harding P. Fractalkine neutralization improves cardiac function after myocardial infarction. Exp Physiol. 2015;100:805\u201317.","journal-title":"Exp Physiol"},{"key":"561_CR25","doi-asserted-by":"crossref","first-page":"e69832","DOI":"10.1371\/journal.pone.0069832","volume":"8","author":"D Taube","year":"2013","unstructured":"Taube D, Xu J, Yang XP, Undrovinas A, Peterson E, Harding P. Fractalkine depresses cardiomyocyte contractility. PLoS ONE. 2013;8:e69832.","journal-title":"PLoS ONE"},{"key":"561_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","volume":"98","author":"IG Poornima","year":"2006","unstructured":"Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 2006;98:596\u2013605.","journal-title":"Circ Res"},{"key":"561_CR27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijcard.2014.01.011","volume":"172","author":"WK Wang","year":"2014","unstructured":"Wang WK, Wang B, Lu QH, Zhang W, Qin WD, Liu XJ, Liu XQ, An FS, Zhang Y, Zhang MX. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. Int J Cardiol. 2014;172:202\u201312.","journal-title":"Int J Cardiol"},{"key":"561_CR28","doi-asserted-by":"crossref","first-page":"e75927","DOI":"10.1371\/journal.pone.0075927","volume":"8","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhang L, Qiao Y, Zhou X, Wu G, Wang L, Peng Y, Dong X, Huang H, Si L, Zhang X, Zhang L, Li J, Wang W, Zhou L, Gao X. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS ONE. 2013;8:e75927.","journal-title":"PLoS ONE"},{"key":"561_CR29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-016-0361-1","volume":"15","author":"V Kandula","year":"2016","unstructured":"Kandula V, Kosuru R, Li H, Yan D, Zhu Q, Lian Q, Ge RS, Xia Z, Irwin MG. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy. Cardiovasc Diabetol. 2016;15:44.","journal-title":"Cardiovasc Diabetol"},{"key":"561_CR30","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","volume":"26","author":"PK Bagul","year":"2015","unstructured":"Bagul PK, Deepthi N, Sultana R, Banerjee SK. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NF\u03baB-p65 and histone 3. J Nutr Biochem. 2015;26:1298\u2013307.","journal-title":"J Nutr Biochem"},{"key":"561_CR31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bbadis.2014.10.013","volume":"1852","author":"T Szkudelski","year":"2015","unstructured":"Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta. 2015;1852:1145\u201354.","journal-title":"Biochim Biophys Acta"},{"key":"561_CR32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/molecules21081009","volume":"21","author":"V Spigoni","year":"2016","unstructured":"Spigoni V, Mena P, Cito M, Fantuzzi F, Bonadonna R, Brighenti F, Dei Cas A, Del Rio D. Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells. Molecules. 2016;21:1009.","journal-title":"Molecules"},{"key":"561_CR33","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/mnfr.201500264","volume":"59","author":"JP Piwowarski","year":"2015","unstructured":"Piwowarski JP, Kiss AK, Granica S, Moeslinger T. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages. Mol Nutr Food Res. 2015;59:2168\u201377.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mnfr.201100677","volume":"56","author":"JA Gim\u00e9nez-Bastida","year":"2012","unstructured":"Gim\u00e9nez-Bastida JA, Gonz\u00e1lez-Sarr\u00edas A, Larrosa M, Tom\u00e1s-Barber\u00e1n F, Esp\u00edn JC, Garc\u00eda-Conesa MT. Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-\u03b1-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res. 2012;56:784\u201396.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR35","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1039\/C4FO00538D","volume":"5","author":"W Liu","year":"2014","unstructured":"Liu W, Ma H, Frost L, Yuan T, Dain JA, Seeram NP. Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. Food Funct. 2014;5:2996\u20133004.","journal-title":"Food Funct."},{"key":"561_CR36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/mnfr.201500827","volume":"60","author":"QA Han","year":"2016","unstructured":"Han QA, Yan C, Wang L, Li G, Xu Y, Xia X. Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK\/PPAR-\u03b3 pathway. Mol Nutr Food Res. 2016;60:1933\u201343.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/mnfr.201500796","volume":"60","author":"I Kang","year":"2016","unstructured":"Kang I, Kim Y, Tom\u00e1s-Barber\u00e1n FA, Esp\u00edn JC, Chung S. Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes. Mol Nutr Food Res. 2016;60:1129\u201338.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.4132","volume":"22","author":"D Ryu","year":"2016","unstructured":"Ryu D, Mouchiroud L, Andreux PA, Katsyuba E, Moullan N, Nicolet-Dit-F\u00e9lix AA, Williams EG, Jha P, Lo Sasso G, Huzard D, Aebischer P, Sandi C, Rinsch C, Auwerx J. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016;22:879\u201388.","journal-title":"Nat Med"},{"key":"561_CR39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.numecd.2013.09.008","volume":"24","author":"L Bresciani","year":"2014","unstructured":"Bresciani L, Calani L, Bocchi L, Delucchi F, Savi M, Ray S, Brighenti F, Stilli D, Del Rio D. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. Nutr Metab Cardiovasc Dis. 2014;24:408\u201315.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"561_CR40","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.2337\/db14-1107","volume":"64","author":"GA Ramirez-Correa","year":"2015","unstructured":"Ramirez-Correa GA, Ma J, Slawson C, Zeidan Q, Lugo-Fagundo NS, Xu M, Shen X, Dong Gao W, Caceres V, Chakir K, DeVine L, Cole RN, Marchionni L, Paolocci N, Hart GW, Murphy AM. Removal of abnormal myofilament O-GlcNAcylation restores Ca2+ sensitivity in diabetic cardiac muscle. Diabetes. 2015;64:3573\u201387.","journal-title":"Diabetes"},{"key":"561_CR41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","volume":"32","author":"GE White","year":"2012","unstructured":"White GE, Greaves DR. Fractalkine: a survivor\u2019s guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol. 2012;32:589\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"561_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yjmcc.2008.05.009","volume":"45","author":"C Husberg","year":"2008","unstructured":"Husberg C, Nyg\u00e5rd S, Finsen AV, Dam\u00e5s JK, Frigessi A, Oie E, Waehre A, Gullestad L, Aukrust P, Yndestad A, Christensen G. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol. 2008;45:261\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"561_CR43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yjmcc.2016.08.020","volume":"101","author":"D Terentyev","year":"2016","unstructured":"Terentyev D, Hamilton S. Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart. J Mol Cell Cardiol. 2016;101:156\u201364.","journal-title":"J Mol Cell Cardiol"},{"key":"561_CR44","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/CIRCULATIONAHA.112.096388","volume":"126","author":"P Zhang","year":"2012","unstructured":"Zhang P, Kirk JA, Ji W, dos Remedios CG, Kass DA, Van Eyk JE, Murphy AM. Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation. 2012;126:1828\u201337.","journal-title":"Circulation"},{"key":"561_CR45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/mnfr.201300931","volume":"58","author":"MA Nu\u00f1ez-Sanchez","year":"2014","unstructured":"Nu\u00f1ez-Sanchez MA, Garcia-Villalba R, Monedero-Saiz T, Garcia-Talavera NV, Gomez-Sanchez MB, Sanchez-Alvarez C, Garcia-Albert AM, Rodriguez-Gil FJ, Ruiz-Marin M, Pastor-Quirante FA, Martinez-Diaz F, Yanez-Gascon MJ, Gonzalez-Sarrias A, Tomas-Barberan FA, Espin JC. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res. 2014;58:1199\u2013211.","journal-title":"Mol Nutr Food Res"},{"key":"561_CR46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1124\/dmd.111.039651","volume":"39","author":"R Gonz\u00e1lez-Barrio","year":"2011","unstructured":"Gonz\u00e1lez-Barrio R, Edwards CA, Crozier A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies. Drug Metab Dispos. 2011;39:1680\u20138.","journal-title":"Drug Metab Dispos"},{"key":"561_CR47","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1021\/jf5040652","volume":"62","author":"B Pfundstein","year":"2014","unstructured":"Pfundstein B, Haubner R, W\u00fcrtele G, Gehres N, Ulrich CM, Owen RW. Pilot walnut intervention study of urolithin bioavailability in human volunteers. J Agric Food Chem. 2014;62:10264\u201373.","journal-title":"J Agric Food Chem"},{"key":"561_CR48","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.1021\/jf301509w","volume":"60","author":"S Tulipani","year":"2012","unstructured":"Tulipani S, Urpi-Sarda M, Garc\u00eda-Villalba R, Rabassa M, L\u00f3pez-Uriarte P, Bull\u00f3 M, J\u00e1uregui O, Tom\u00e1s-Barber\u00e1n F, Salas-Salvad\u00f3 J, Esp\u00edn JC, Andr\u00e9s-Lacueva C. Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome. J Agric Food Chem. 2012;60:8930\u201340.","journal-title":"J Agric Food Chem"},{"key":"561_CR49","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/jf900725e","volume":"57","author":"A Gonz\u00e1lez-Sarr\u00edas","year":"2009","unstructured":"Gonz\u00e1lez-Sarr\u00edas A, Azor\u00edn-Ortu\u00f1o M, Y\u00e1\u00f1ez-Gasc\u00f3n MJ, Tom\u00e1s-Barber\u00e1n FA, Garc\u00eda-Conesa MT, Esp\u00edn JC. Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. J Agric Food Chem. 2009;57:5623\u201332.","journal-title":"J Agric Food Chem"},{"key":"561_CR50","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1021\/jf0723864","volume":"55","author":"JC Esp\u00edn","year":"2007","unstructured":"Esp\u00edn JC, Gonz\u00e1lez-Barrio R, Cerd\u00e1 B, L\u00f3pez-Bote C, Rey AI, Tom\u00e1s-Barber\u00e1n FA. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem. 2007;55:10476\u201385.","journal-title":"J Agric Food Chem"},{"key":"561_CR51","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1039\/C4FO00092G","volume":"5","author":"MV Selma","year":"2014","unstructured":"Selma MV, Beltran D, Garcia-Villalba R, Espin JC, Tomas-Barberan FA. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct. 2014;5:1779\u201384.","journal-title":"Food Funct"},{"key":"561_CR52","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/acschemneuro.5b00051","volume":"6","author":"M Gasperotti","year":"2015","unstructured":"Gasperotti M, Passamonti S, Tramer F, Masuero D, Guella G, Mattivi F, Vrhovsek U. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem Neurosci. 2015;6:1341\u201352.","journal-title":"ACS Chem Neurosci"},{"key":"561_CR53","unstructured":"Cros G, Crozier A, Dall\u2019Asta M, Del Rio D, Magous R, Oiry C. Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion; 2013. Patent WO2015055736 A1, 23 Apr 2015."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T09:16:48Z","timestamp":1499332608000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0561-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]},"article-number":"80"}}